Peer review reports
From: Associated risk factors with disease severity and antiviral drug therapy in patients with COVID-19
Original Submission | ||
---|---|---|
2 Sep 2020 | Submitted | Original manuscript |
4 Oct 2020 | Reviewed | Reviewer Report |
10 Oct 2020 | Reviewed | Reviewer Report - KHALID AHMAD ALSUNAIDAR |
13 Oct 2020 | Reviewed | Reviewer Report |
3 Nov 2020 | Author responded | Author comments - Xiaowei Gong |
Resubmission - Version 2 | ||
3 Nov 2020 | Submitted | Manuscript version 2 |
15 Nov 2020 | Reviewed | Reviewer Report |
22 Nov 2020 | Reviewed | Reviewer Report - KHALID AHMAD ALSUNAIDAR |
5 Jan 2021 | Reviewed | Reviewer Report |
27 Jan 2021 | Author responded | Author comments - Xiaowei Gong |
Resubmission - Version 3 | ||
27 Jan 2021 | Submitted | Manuscript version 3 |
30 May 2021 | Author responded | Author comments - Xiaowei Gong |
Resubmission - Version 4 | ||
30 May 2021 | Submitted | Manuscript version 4 |
Publishing | ||
3 Jun 2021 | Editorially accepted | |
10 Jun 2021 | Article published | 10.1186/s12879-021-06282-6 |